Gi Uk Jeong
Gi Uk Jeong
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
4Present Address: Division of Infectious Diseases, Department of Pediatrics, Boston Children’s Hospital, Boston, MA USA
5Present Address: Department of Pediatrics, Harvard Medical School, Boston, MA USA
1,4,5,#,
Insu Hwang
Insu Hwang
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
6Present Address: Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
1,6,#,
Wooseong Lee
Wooseong Lee
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
1,#,
Ji Hyun Choi
Ji Hyun Choi
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
1,#,
Gun Young Yoon
Gun Young Yoon
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
1,
Hae Soo Kim
Hae Soo Kim
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
1,
Jeong-Sun Yang
Jeong-Sun Yang
2Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
2,
Kyung-Chang Kim
Kyung-Chang Kim
2Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
2,
Joo-Yeon Lee
Joo-Yeon Lee
2Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
2,
Seong-Jun Kim
Seong-Jun Kim
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
1,
Young-Chan Kwon
Young-Chan Kwon
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
3Medical Chemistry and Pharmacology, University of Science and Technology (UST), Daejeon, Republic of Korea
1,3,✉,
Kyun-Do Kim
Kyun-Do Kim
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
1,✉
1Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea
2Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
3Medical Chemistry and Pharmacology, University of Science and Technology (UST), Daejeon, Republic of Korea
4Present Address: Division of Infectious Diseases, Department of Pediatrics, Boston Children’s Hospital, Boston, MA USA
5Present Address: Department of Pediatrics, Harvard Medical School, Boston, MA USA
6Present Address: Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
Collection date 2024 Sep.
Subject terms: Viral infection, Transgenic organisms
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.